RedC Biotech, a budding company founded by Dr. Ari Gargir, is developing technology to cultivate red blood cells from stem cells at scale. The approach intends to create universal donor blood types to address global shortages that result in millions of deaths annually. By using large bioreactors, the firm aims to produce transfusion-ready blood in sufficient quantities to serve hospitals worldwide, potentially revolutionizing emergency and routine blood supply, particularly in low-resource settings.